IBB241129C117000
- 0.00
- 0.000.00%
iShares Biotechnology ETF Newsroom
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
Market Climbs, Bitcoin Close to $100k | Live Stock
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Friday Ahead of Business Activity Data
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Snowflake Stimulates Lagging Market
Gilead Sciences Analyst Ratings
Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207
Biogen Analyst Ratings
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Decoding Amgen's Options Activity: What's the Big Picture?
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside